Prevention of vascular inflammation by nanoparticle targeting of adherent neutrophils
- 23 February 2014
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Nanotechnology
- Vol. 9 (3), 204-210
- https://doi.org/10.1038/nnano.2014.17
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Delivery of nanoparticle‐complexed drugs across the vascular endothelial barrier via caveolaeIUBMB Life, 2011
- The Acute Respiratory Distress Syndrome: Pathogenesis and TreatmentAnnual Review Of Pathology-Mechanisms Of Disease, 2011
- LFA-1 and Mac-1 Define Characteristically Different Intralumenal Crawling and Emigration Patterns for Monocytes and Neutrophils In SituThe Journal of Immunology, 2010
- Size and Dynamics of Caveolae Studied Using Nanoparticles in Living Endothelial CellsACS Nano, 2009
- Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injuryNature Medicine, 2009
- Pharmacological Preconditioning of Mesenchymal Stem Cells with Trimetazidine (1-[2,3,4-Trimethoxybenzyl]piperazine) Protects Hypoxic Cells against Oxidative Stress and Enhances Recovery of Myocardial Function in Infarcted Heart through Bcl-2 ExpressionJournal of Pharmacology and Experimental Therapeutics, 2009
- Nonmuscle myosin light-chain kinase mediates neutrophil transmigration in sepsis-induced lung inflammation by activating β2 integrinsNature Immunology, 2008
- The vessel wall and its interactionsBlood, 2008
- Spleen Tyrosine Kinase Syk Is Necessary for E-Selectin-Induced αLβ2 Integrin-Mediated Rolling on Intercellular Adhesion Molecule-1Immunity, 2007
- Piceatannol (3,4,3′,5′-tetrahydroxy-trans-stilbene) is a naturally occurring protein-tyrosine kinase inhibitorBiochemical and Biophysical Research Communications, 1989